Acknowledgement
This work was supported by a National Research Foundation of Korea (NRF) grant (NRF-2016R1D1A3B03936377 and NRF-2019R1I1A1A01043808 to YS Jang, NRF-2019R1I1A3A01048952 to PH Kim) and a 2016 Research Grant from Kangwon National University to PH Kim.
References
- Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252. https://doi.org/10.1038/32588
- Morelli AE, Thomson AW. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003;196:125-146. https://doi.org/10.1046/j.1600-065X.2003.00079.x
- Hubo M, Trinschek B, Kryczanowsky F, Tuettenberg A, Steinbrink K, Jonuleit H. Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunol 2013;4:82.
- Svajger U, Rozman P. Tolerogenic dendritic cells: molecular and cellular mechanisms in transplantation. J Leukoc Biol 2014;95:53-69. https://doi.org/10.1189/jlb.0613336
- Turnquist HR, Raimondi G, Zahorchak AF, Fischer RT, Wang Z, Thomson AW. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol 2007;178:7018-7031. https://doi.org/10.4049/jimmunol.178.11.7018
- Munder M, Eichmann K, Moran JM, Centeno F, Soler G, Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 1999;163:3771-3777. https://doi.org/10.4049/jimmunol.163.7.3771
- Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 2000;164:3596-3599. https://doi.org/10.4049/jimmunol.164.7.3596
- Rodriguez PC, Quiceno DG, Ochoa AC. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 2007;109:1568-1573. https://doi.org/10.1182/blood-2006-06-031856
- Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, Marshall B, Chandler P, Antonia SJ, Burgess R, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002;297:1867-1870. https://doi.org/10.1126/science.1073514
- Mizumoto N, Kumamoto T, Robson SC, Sevigny J, Matsue H, Enjyoji K, Takashima A. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 2002;8:358-365. https://doi.org/10.1038/nm0402-358
- Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol 2009;39:3147-3159. https://doi.org/10.1002/eji.200839103
- Legrand D, Elass E, Carpentier M, Mazurier J. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 2005;62:2549-2559. https://doi.org/10.1007/s00018-005-5370-2
- Moreno-Exposito L, Illescas-Montes R, Melguizo-Rodriguez L, Ruiz C, Ramos-Torrecillas J, de Luna-Bertos E. Multifunctional capacity and therapeutic potential of lactoferrin. Life Sci 2018;195:61-64. https://doi.org/10.1016/j.lfs.2018.01.002
- Haversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB. Cell Immunol 2002;220:83-95. https://doi.org/10.1016/S0008-8749(03)00006-6
- Togawa J, Nagase H, Tanaka K, Inamori M, Nakajima A, Ueno N, Saito T, Sekihara H. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol 2002;17:1291-1298. https://doi.org/10.1046/j.1440-1746.2002.02868.x
- Zimecki M, Kocieba M, Chodaczek G, Houszka M, Kruzel ML. Lactoferrin ameliorates symptoms of experimental encephalomyelitis in Lewis rats. J Neuroimmunol 2007;182:160-166. https://doi.org/10.1016/j.jneuroim.2006.10.008
- Yin H, Cheng L, Agarwal C, Agarwal R, Ju C. Lactoferrin protects against concanavalin A-induced liver injury in mice. Liver Int 2010;30:623-632. https://doi.org/10.1111/j.1478-3231.2009.02199.x
- Kim PH, Jang YS, Song H-E, Seo GY, Kang SG, Lee JH, Kwon BE, Ko HJ. Mechanism underlying the induction of Foxp3+ regulatory T cells by lactoferrin. J Immunol 2018;200:47.16.
- Bhatt S, Qin J, Bennett C, Qian S, Fung JJ, Hamilton TA, Lu L. All-trans retinoic acid induces arginase-1 and inducible nitric oxide synthase-producing dendritic cells with T cell inhibitory function. J Immunol 2014;192:5098-5108. https://doi.org/10.4049/jimmunol.1303073
- Turner MS, Kane LP, Morel PA. Dominant role of antigen dose in CD4+ Foxp3+ regulatory T cell induction and expansion. J Immunol 2009;183:4895-4903. https://doi.org/10.4049/jimmunol.0901459
- Semple K, Nguyen A, Yu Y, Wang H, Anasetti C, Yu XZ. Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling. Blood 2011;117:3096-3103. https://doi.org/10.1182/blood-2010-08-301275
- Xia CQ, Peng R, Beato F, Clare-Salzler MJ. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand J Immunol 2005;62:45-54. https://doi.org/10.1111/j.1365-3083.2005.01640.x
- Kim N, Park CS, Im SA, Kim JW, Lee JH, Park YJ, Song S, Lee CK. Minocycline promotes the generation of dendritic cells with regulatory properties. Oncotarget 2016;7:52818-52831. https://doi.org/10.18632/oncotarget.10810
- Lee JH, Park CS, Jang S, Kim JW, Kim SH, Song S, Kim K, Lee CK. Tolerogenic dendritic cells are efficiently generated using minocycline and dexamethasone. Sci Rep 2017;7:15087.
- Parry RV, Rumbley CA, Vandenberghe LH, June CH, Riley JL. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes. J Immunol 2003;171:166-174. https://doi.org/10.4049/jimmunol.171.1.166
- Kim JM, Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev 2006;212:86-98. https://doi.org/10.1111/j.0105-2896.2006.00426.x
- Chang J, Thangamani S, Kim MH, Ulrich B, Morris SM Jr, Kim CH. Retinoic acid promotes the development of Arg1-expressing dendritic cells for the regulation of T-cell differentiation. Eur J Immunol 2013;43:967-978. https://doi.org/10.1002/eji.201242772
- Chung DJ, Rossi M, Romano E, Ghith J, Yuan J, Munn DH, Young JW. Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 2009;114:555-563. https://doi.org/10.1182/blood-2008-11-191197
- Creery WD, Diaz-Mitoma F, Filion L, Kumar A. Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype. Eur J Immunol 1996;26:1273-1277. https://doi.org/10.1002/eji.1830260614
- Elass-Rochard E, Legrand D, Salmon V, Roseanu A, Trif M, Tobias PS, Mazurier J, Spik G. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect Immun 1998;66:486-491. https://doi.org/10.1128/IAI.66.2.486-491.1998
- Tze LE, Horikawa K, Domaschenz H, Howard DR, Roots CM, Rigby RJ, Way DA, Ohmura-Hoshino M, Ishido S, Andoniou CE, et al. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J Exp Med 2011;208:149-165. https://doi.org/10.1084/jem.20092203
- Davidson LA, Lonnerdal B. Persistence of human milk proteins in the breast-fed infant. Acta Paediatr Scand 1987;76:733-740. https://doi.org/10.1111/j.1651-2227.1987.tb10557.x
- Kim PH, Kagnoff MF. Transforming growth factor beta 1 increases IgA isotype switching at the clonal level. J Immunol 1990;145:3773-3778. https://doi.org/10.4049/jimmunol.145.11.3773
- Jang YS, Seo GY, Lee JM, Seo HY, Han HJ, Kim SJ, Jin BR, Kim HJ, Park SR, Rhee KJ, et al. Lactoferrin causes IgA and IgG2b isotype switching through betaglycan binding and activation of canonical TGF-β signaling. Mucosal Immunol 2015;8:906-917. https://doi.org/10.1038/mi.2014.121
- Cong Y, Feng T, Fujihashi K, Schoeb TR, Elson CO. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci U S A 2009;106:19256-19261. https://doi.org/10.1073/pnas.0812681106
- Tsuji M, Komatsu N, Kawamoto S, Suzuki K, Kanagawa O, Honjo T, Hori S, Fagarasan S. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 2009;323:1488-1492. https://doi.org/10.1126/science.1169152
- Masson PL, Heremans JF, Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 1969;130:643-658. https://doi.org/10.1084/jem.130.3.643
- MacManus CF, Collins CB, Nguyen TT, Alfano RW, Jedlicka P, de Zoeten EF. VEN-120, a recombinant human lactoferrin, promotes a regulatory T cell [Treg] phenotype and drives resolution of inflammation in distinct murine models of inflammatory bowel disease. J Crohns Colitis 2017;11:1101-1112. https://doi.org/10.1093/ecco-jcc/jjx056